Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Language
Affiliation country
Publication year range
1.
BMC Infect Dis ; 24(1): 403, 2024 Apr 15.
Article in English | MEDLINE | ID: mdl-38622539

ABSTRACT

BACKGROUND: Monkeypox is an emerging infectious disease with confirmed cases and deaths in several parts of the world. In light of this crisis, this study aims to analyze the global knowledge pattern of monkeypox-related patents and explore current trends and future technical directions in the medical development of monkeypox to inform research and policy. METHODS: A comprehensive study of 1,791 monkeypox-related patents worldwide was conducted using the Derwent patent database by descriptive statistics, social network method and linear regression analysis. RESULTS: Since the 21st century, the number of monkeypox-related patents has increased rapidly, accompanied by increases in collaboration between commercial and academic patentees. Enterprises contributed the most in patent quantity, whereas the initial milestone patent was filed by academia. The core developments of technology related to the monkeypox include biological and chemical medicine. The innovations of vaccines and virus testing lack sufficient patent support in portfolios. CONCLUSIONS: Monkeypox-related therapeutic innovation is geographically limited with strong international intellectual property right barriers though it has increased rapidly in recent years. The transparent licensing of patent knowledge is driven by the merger and acquisition model, and the venture capital, intellectual property and contract research organization model. Currently, the patent thicket phenomenon in the monkeypox field may slow the progress of efforts to combat monkeypox. Enterprises should pay more attention to the sharing of technical knowledge, make full use of drug repurposing strategies, and promote innovation of monkeypox-related technology in hotspots of antivirals (such as tecovirimat, cidofovir, brincidofovir), vaccines (JYNNEOS, ACAM2000), herbal medicine and gene therapy.


Subject(s)
Communicable Diseases, Emerging , Mpox (monkeypox) , Vaccines , Humans , Communicable Diseases, Emerging/drug therapy , Communicable Diseases, Emerging/epidemiology , Mpox (monkeypox)/drug therapy , Mpox (monkeypox)/epidemiology , Technology
2.
Med Biol Eng Comput ; 2024 Feb 16.
Article in English | MEDLINE | ID: mdl-38363486

ABSTRACT

In light of the situation and the characteristics of Omicron, the country has continuously optimized the rules for the prevention and control of COVID-19. The global epidemic is still spreading, and new cases of infection continue to emerge in China. To facilitate the infected person to estimate the course of virus infection, a prediction model for predicting negative conversion time is proposed in this article. The clinical features of Omicron-infected patients in Shandong Province in the first half of 2022 are retrospectively studied. These features are grouped by disease diagnosis result, clinical sign, traditional Chinese medicine symptoms, and drug use. These features are input to the eXtreme Gradient Boosting (XGBoost) model, and the output is the predicted number of negative conversion days. At the same time, XGBoost is used as the underlying algorithm of the conformal prediction (CP) framework, which can realize the probability interval estimation with a controllable error rate. The results show that the proposed model has a mean absolute error of 3.54 days and has the shortest interval prediction result. This shows that the method in this paper can carry more decision-making information and help people better understand the disease and self-estimate the course of the disease to a certain extent.

3.
Biomed Res Int ; 2022: 6825576, 2022.
Article in English | MEDLINE | ID: mdl-35782081

ABSTRACT

Objective: Artificial intelligence-powered screening systems of coronavirus disease 2019 (COVID-19) are urgently demanding since the ongoing outbreak of SARS-CoV-2 worldwide. Chest CT or X-ray is not sufficient to support the large-scale screening of COVID-19 because mildly-infected patients do not have imaging features on these images. Therefore, it is imperative to exploit supplementary medical imaging strategies. Traditional Chinese medicine has played an essential role in the fight against COVID-19. Methods: In this paper, we conduct two kinds of verification experiments based on a newly-collected multi-modality dataset, which consists of three types of modalities: tongue images, chest CT scans, and X-ray images. First, we study a binary classification experiment on tongue images to verify the discriminative ability between COVID-19 and non-COVID-19. Second, we design extensive multimodality experiments to validate whether introducing tongue image can improve the screening accuracy of COVID-19 based on chest CT or X-ray images. Results: Tongue image screening of COVID-19 showed that the accuracy (ACC), sensitivity (SEN), specificity (SPEC), and Matthew correlation coefficient (MCC) of the improved AlexNet and Googlenet both reached 98.39%, 98.97%, 96.67%, and 99.11%. The fusion of chest CT and tongue images used a tandem multimodal classifier fusion strategy to achieve optimal classification, and the results and screening accuracy of COVID-19 reached 98.98%, resulting in a significant improvement of 4.75% the highest accuracy in 375 years compared with the single-modality model. The fusion of chest x-rays and tongue images also had good classification accuracy. Conclusions: Both experimental results demonstrate that tongue image not only has an excellent discriminative ability for screening COVID-19 but also can improve the screening accuracy based on chest CT or X-rays. To the best of our knowledge, it is the first work that verifies the effectiveness of tongue image on screening COVID-19. This paper provides a new perspective and a novel solution that contributes to large-scale screening toward fast stopping the pandemic of COVID-19.


Subject(s)
Artificial Intelligence , COVID-19 , COVID-19/diagnostic imaging , Humans , Medicine, Chinese Traditional , SARS-CoV-2 , Tongue/diagnostic imaging
4.
Front Med (Lausanne) ; 9: 925369, 2022.
Article in English | MEDLINE | ID: mdl-35847804

ABSTRACT

Two years after COVID-19 came into being, many technologies have been developed to bring highly promising bedside methods to help fight this epidemic disease. However, owing to viral mutation, how far the promise can be realized remains unclear. Patents might act as an additional source of information for informing research and policy and anticipating important future technology developments. A comprehensive study of 3741 COVID-19-related patents (3,543 patent families) worldwide was conducted using the Derwent Innovation database. Descriptive statistics and social network analysis were used in the patent landscape. The number of COVID-19 applications, especially those related to treatment and prevention, continued to rise, accompanied by increases in governmental and academic patent assignees. Although China dominated COVID-19 technologies, this position is worth discussing, especially in terms of the outstanding role of India and the US in the assignee collaboration network as well as the outstanding invention portfolio in Italy. Intellectual property barriers and racist treatment were reduced, as reflected by individual partnerships, transparent commercial licensing and diversified portfolios. Critical technological issues are personalized immunity, traditional Chinese medicine, epidemic prediction, artificial intelligence tools, and nucleic acid detection. Notable challenges include balancing commercial competition and humanitarian interests. The results provide a significant reference for decision-making by researchers, clinicians, policymakers, and investors with an interest in COVID-19 control.

5.
Digital Chinese Medicine ; (4): 59-67, 2022.
Article in English | WPRIM | ID: wpr-974084

ABSTRACT

@#Objective The resting-state functional magnetic resonance imaging (rs-fMRI) method was used to observe brain activity and its functional connection upon electroacupuncture stimulation at bilateral uterine acupoints (EX-CA1), as well as to investigate the mechanism of acupuncture in the treatment of gynecological diseases. Methods Twenty-two healthy female subjects were stimulated by electroacupuncture at bilateral uterine acupoints; rs-fMRI data of the brain were acquired and standardized. Degree centrality (DC), amplitude of low-frequency fluctuation (ALFF), and regional homogeneity (ReHo) were used to analyze local spontaneous brain activity via acupuncture. An independent component analysis was used to evaluate the functional connectivity of the resting brain networks after acupuncture. Results Analytical results showed that the neural activity intensity of the precuneus lobe, orbitofrontal cortex, lingual gyrus, amygdala, and posterior central gyrus decreased after acupuncture (voxel P < 0.001, cluster P < 0.05). Functional connectivity analysis revealed weakened auditory and right frontal-parietal networks (voxel P < 0.001, cluster P < 0.05), enhanced visual network (voxel P < 0.001, cluster P < 0.05), and synergistic auditory network and hypothalamic-pituitary system. Conclusion Significant differences in neural activity and functional connectivity in specific brain regions were observed after acupuncture intervention at uterine acupoints; the hypothalamic-pituitary system also showed various active states in different brain regions. It is speculated that the effective mechanism of acupuncture at uterine acupoints is related to the regulation of reproductive hormones, emotional changes, and somatic sensations. Therefore, the methods used in this study could clarify the neural mechanism of uterine-point acupuncture in the treatment of gynecological diseases and may serve as a reference for other studies pertaining to acupuncture.

SELECTION OF CITATIONS
SEARCH DETAIL